skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Rheumatoid_Arthritis_DMHC_Report_Front_Cover

Discover the leading Rheumatoid Arthritis (RA) treatments of 2017. At Datamonitor Healthcare, we’ve quadrupled our business, covering more than 90% of prescription medicines in the major markets. We are known for offering the best forecasts, coverage, analysis and support. Which are good enough reasons to download our Rheumatoid Arthritis Sample Pack today.

In it, you will discover:

 

  • Which inhibitor currently marketed for RA in the US and Japan, is anticipated to launch in the five major EU markets over the forecast period

 

  • Which inhibitor significantly reduced the radiographic progression of structural joint damage compared to a placebo in the long-term extension study, RA-BEYOND (Lilly, 2016b)

 

  • The sales of Janus Kinase inhibitors in the US, Japan, and five major EU markets ($m), 2016–25

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or email us your inquiry, so we can provide you the best possible customer service:
pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: